Clinical trials in Leiden – page 25

401 clinical trials in Leiden, The Netherlands across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in the NetherlandsKlinischOnderzoek.nl

Leiden at a glance

401

clinical trials

Research sites4

Quick filters

401 trials in Leiden

Open in trial search

Study on BI 1015550 for Improving Lung Function in Patients with Progressive Fibrosing Interstitial Lung Diseases

Investigational

The Netherlands

Participants:65+ years
Substances:Bi 1015550
Sponsor:Boehringer Ingelheim Espana S.A.

Contact Research Centre

Study on the Safety and Effectiveness of Acasunlimab and Pembrolizumab for Patients with Recurrent Non-Small Cell Lung Cancer

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Acasunlimab
Sponsor:Genmab A/S

Contact Research Centre

Study on the Safety and Effects of VX-264 for Patients with Type 1 Diabetes

InvestigationalNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Vx-264
Sponsor:Vertex Pharmaceuticals Inc.

Contact Research Centre

Non-small cell lung cancer recurrent+1

Not recruiting

InvestigationalNo placebo

Study of CLN-081 tablets in patients with non-small cell lung cancer with EGFR exon 20 insertion mutations who have previously received platinum chemotherapy

InvestigationalNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Cln-081
Sponsor:Cullinan Pearl Corp.

Contact Research Centre

Study of inhaled alpha1-proteinase inhibitor (Kamada-AAT) in adults with alpha-1 antitrypsin deficiency and moderate to severe airflow limitation

Not recruiting

Investigational

Study of inhaled alpha1-proteinase inhibitor (Kamada-AAT) in adults with alpha-1 antitrypsin deficiency and moderate to severe airflow limitation

Investigational

The Netherlands

Participants:18–64 years · 65+ years
Substances:Human Alpha1-Proteinase Inhibitor
Sponsor:Kamada Ltd.

Contact Research Centre

Study on Efgartigimod IV for Adults with Seronegative Generalized Myasthenia Gravis

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:Efgartigimod Alfa
Sponsor:Argenx

Contact Research Centre

Ductal adenocarcinoma of pancreas

Not recruiting

InvestigationalNo placebo

Study of SGM-101 fluorescent imaging agent to guide surgery in patients with pancreatic cancer who received prior treatment

InvestigationalNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Chimeric Monoclonal Antibody Against Carcinoembryonic Antigen Conjugated To Fluorochrome Bm-104
Sponsor:Leids Universitair Medisch Centrum (LUMC)

Contact Research Centre

Study on Rheumatoid Arthritis: Evaluating Methotrexate, Golimumab, and Hydroxychloroquine Sulfate for Patients with Autoantibodies and Response to Glucocorticoids

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Adalimumab
Sponsor:Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Contact Research Centre

Neonatal alloimmune thrombocytopenia

Not recruiting

InvestigationalNo placebo

Study on the Safety and Effects of RLYB212 in Pregnant Women at Risk for Fetal and Neonatal Alloimmune Thrombocytopenia

InvestigationalNo placebo

The Netherlands

Participants:18–64 years
Substances:Anti-(Integrin Beta-3) Human Monoclonal Antibody
Sponsor:Rallybio Ipa LLC

Contact Research Centre

Gastrointestinal stromal tumour

Not recruiting

Registered drugNo placebo

Study on the Effect of Extending Imatinib Treatment from Three to Five Years for Patients with High-Risk Gastrointestinal Stromal Tumor (GIST)

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Imatinib
Sponsor:Region Skane

Contact Research Centre

Study on Long-Term Safety and Effectiveness of Vamorolone in Boys with Duchenne Muscular Dystrophy Who Completed Previous Vamorolone Studies

Registered drugNo placebo

The Netherlands

Participants:0–17 years
Substances:Vamorolone
Sponsor:Santhera Pharmaceuticals (Schweiz) AG

Contact Research Centre

Study on the Safety and Effects of PDC*lung01 Vaccine with Pemetrexed or Pembrolizumab for Patients with Non-Small Cell Lung Cancer

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Pembrolizumab
Sponsor:PDC line pharma

Contact Research Centre

Other cities in the Netherlands

The busiest research cities in the country

All 103 cities in the Netherlands

Clinical research in Leiden

What the registry says about research in the country

01 Infectious Diseases Research

Innovative studies focusing on viral infections including trials evaluating vaccines against yellow fever, influenza, and mpox. Research includes assessment of antibody responses and vaccine effectiveness in different populations.

Influenza vaccine efficacy in elderly
Yellow fever prophylaxis
Mpox booster vaccination

Particular emphasis on preventive strategies and immune response evaluation.

02 Neurological Studies

Comprehensive research targeting neurological conditions, including investigations into Parkinson's disease treatments and neural response patterns. Studies examine innovative therapeutic approaches.

Parkinson's Disease treatments
CNS response analysis
Cerebral Amyloid Angiopathy

Focus on developing targeted therapies and understanding brain mechanisms.

03 Cancer and Chronic Conditions

Advanced research in oncology and chronic diseases, including studies on gastric cancer imaging and T-cell lymphoma treatments. Investigations into kidney disease management.

Advanced solid tumors
Gastric cancer diagnosis
Chronic kidney disease

Emphasis on innovative diagnostic techniques and treatment approaches.

Back to the Netherlands All countries

Clinical trials in Leiden – page 25

401 trials in Leiden

Interstitial lung disease

Study on BI 1015550 for Improving Lung Function in Patients with Progressive Fibrosing Interstitial Lung Diseases

Non-small cell lung cancer

Study on the Safety and Effectiveness of Acasunlimab and Pembrolizumab for Patients with Recurrent Non-Small Cell Lung Cancer

Diabetes mellitus

Study on the Safety and Effects of VX-264 for Patients with Type 1 Diabetes

Non-small cell lung cancer recurrent+1

Study of CLN-081 tablets in patients with non-small cell lung cancer with EGFR exon 20 insertion mutations who have previously received platinum chemotherapy

Study of inhaled alpha1-proteinase inhibitor (Kamada-AAT) in adults with alpha-1 antitrypsin deficiency and moderate to severe airflow limitation

Study of inhaled alpha1-proteinase inhibitor (Kamada-AAT) in adults with alpha-1 antitrypsin deficiency and moderate to severe airflow limitation

Myasthenia gravis

Study on Efgartigimod IV for Adults with Seronegative Generalized Myasthenia Gravis

Ductal adenocarcinoma of pancreas

Study of SGM-101 fluorescent imaging agent to guide surgery in patients with pancreatic cancer who received prior treatment

Rheumatoid arthritis

Study on Rheumatoid Arthritis: Evaluating Methotrexate, Golimumab, and Hydroxychloroquine Sulfate for Patients with Autoantibodies and Response to Glucocorticoids

Neonatal alloimmune thrombocytopenia

Study on the Safety and Effects of RLYB212 in Pregnant Women at Risk for Fetal and Neonatal Alloimmune Thrombocytopenia

Gastrointestinal stromal tumour

Study on the Effect of Extending Imatinib Treatment from Three to Five Years for Patients with High-Risk Gastrointestinal Stromal Tumor (GIST)

Duchenne muscular dystrophy

Study on Long-Term Safety and Effectiveness of Vamorolone in Boys with Duchenne Muscular Dystrophy Who Completed Previous Vamorolone Studies

Non-small cell lung cancer

Study on the Safety and Effects of PDC*lung01 Vaccine with Pemetrexed or Pembrolizumab for Patients with Non-Small Cell Lung Cancer

Filter the trials

Other cities in the Netherlands

Clinical research in Leiden

Prefer not to search? Our Concierge searches the trials for you.

Clinical trials in Leiden – page 25

401 trials in Leiden

Non-small cell lung cancer recurrent+1

Other cities in the Netherlands

Related

Clinical research in Leiden

Prefer not to search? Our Concierge searches the trials for you.